NET PROFIT (x1000 EUR)
EMPLOYEES
Jan Wallmarks medicinska konsult AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
0
|
-17
|
-25 |
| EBITDA |
0
|
-21
|
-25 |
| Total assets |
5
|
5
|
25 |
| Current assets |
5
|
5
|
25 |
| Current liabilities |
0
|
0
|
1 |
| Equity capital |
5
|
5
|
20 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
0
|
1
|
0 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
100%
|
100%
|
80.0% |
| Turnover per employee | 0 | ||
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
0%
|
-340.0%
|
-100% |
| Current ratio | 2500% | ||
| Return on equity (ROE) |
0%
|
-340.0%
|
-125.0% |
| Change turnover |
0
|
0
|
-25 |
| Change turnover % | -100% | ||
| Chg. No. of employees |
-1
|
1
|
-1 |
| Chg. No. of employees % | -100% | -100% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.